437 related articles for article (PubMed ID: 23832090)
1. In vivo imaging of glucose uptake and metabolism in tumors.
Walker-Samuel S; Ramasawmy R; Torrealdea F; Rega M; Rajkumar V; Johnson SP; Richardson S; Gonçalves M; Parkes HG; Arstad E; Thomas DL; Pedley RB; Lythgoe MF; Golay X
Nat Med; 2013 Aug; 19(8):1067-72. PubMed ID: 23832090
[TBL] [Abstract][Full Text] [Related]
2. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
[TBL] [Abstract][Full Text] [Related]
3. Mapping brain glucose uptake with chemical exchange-sensitive spin-lock magnetic resonance imaging.
Jin T; Mehrens H; Hendrich KS; Kim SG
J Cereb Blood Flow Metab; 2014 Aug; 34(8):1402-10. PubMed ID: 24865996
[TBL] [Abstract][Full Text] [Related]
4. The Evolving Role of Succinate in Tumor Metabolism: An
Garrigue P; Bodin-Hullin A; Balasse L; Fernandez S; Essamet W; Dignat-George F; Pacak K; Guillet B; Taïeb D
J Nucl Med; 2017 Nov; 58(11):1749-1755. PubMed ID: 28619735
[TBL] [Abstract][Full Text] [Related]
5. Quantification of hydroxyl exchange of D-Glucose at physiological conditions for optimization of glucoCEST MRI at 3, 7 and 9.4 Tesla.
Zaiss M; Anemone A; Goerke S; Longo DL; Herz K; Pohmann R; Aime S; Rivlin M; Navon G; Golay X; Scheffler K
NMR Biomed; 2019 Sep; 32(9):e4113. PubMed ID: 31313865
[TBL] [Abstract][Full Text] [Related]
6. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[
Capozza M; Anemone A; Dhakan C; Della Peruta M; Bracesco M; Zullino S; Villano D; Terreno E; Longo DL; Aime S
Mol Imaging Biol; 2022 Feb; 24(1):126-134. PubMed ID: 34383241
[TBL] [Abstract][Full Text] [Related]
7. From tumor biology to clinical Pet: a review of positron emission tomography (PET) in oncology.
Kubota K
Ann Nucl Med; 2001 Dec; 15(6):471-86. PubMed ID: 11831394
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck Cancer.
Wang J; Weygand J; Hwang KP; Mohamed AS; Ding Y; Fuller CD; Lai SY; Frank SJ; Zhou J
Sci Rep; 2016 Jul; 6():30618. PubMed ID: 27461165
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.
Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA
Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of tumor metabolism and apoptosis.
Haberkorn U; Altmann A; Mier W; Eisenhut M
Ernst Schering Found Symp Proc; 2007; (4):125-52. PubMed ID: 18811056
[TBL] [Abstract][Full Text] [Related]
11. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell metabolism imaging.
Plathow C; Weber WA
J Nucl Med; 2008 Jun; 49 Suppl 2():43S-63S. PubMed ID: 18523065
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
[TBL] [Abstract][Full Text] [Related]
14. d-glucose weighted chemical exchange saturation transfer (glucoCEST)-based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patients.
Xu X; Sehgal AA; Yadav NN; Laterra J; Blair L; Blakeley J; Seidemo A; Coughlin JM; Pomper MG; Knutsson L; van Zijl PCM
Magn Reson Med; 2020 Jul; 84(1):247-262. PubMed ID: 31872916
[TBL] [Abstract][Full Text] [Related]
15. Dependence of FDG uptake on tumor microenvironment.
Pugachev A; Ruan S; Carlin S; Larson SM; Campa J; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):545-53. PubMed ID: 15890599
[TBL] [Abstract][Full Text] [Related]
16. GlucoCEST imaging with on-resonance variable delay multiple pulse (onVDMP) MRI.
Xu X; Xu J; Chan KWY; Liu J; Liu H; Li Y; Chen L; Liu G; van Zijl PCM
Magn Reson Med; 2019 Jan; 81(1):47-56. PubMed ID: 30058240
[TBL] [Abstract][Full Text] [Related]
17. Enhanced glucose metabolism mediated by CD147 is associated with
Zhang Y; Liu J; Sun Y; Yu X; Wang J; Dai D; Zhu Y; Song X; Zhu L; Li X; Xu W
Thorac Cancer; 2020 May; 11(5):1245-1257. PubMed ID: 32162491
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
Chitneni SK; Bida GT; Zalutsky MR; Dewhirst MW
J Nucl Med; 2014 Jul; 55(7):1192-7. PubMed ID: 24854792
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cancer-derived EMT cells in the accumulation of
Sugita S; Yamato M; Hatabu T; Kataoka Y
Sci Rep; 2021 May; 11(1):9668. PubMed ID: 33994540
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of [(18)F]F-GAZ, a novel oxygen-mimetic azomycin-glucose conjugate, for imaging hypoxic tumor.
Wuest M; Kumar P; Wang M; Yang J; Jans HS; Wiebe LI
Cancer Biother Radiopharm; 2012 Oct; 27(8):473-80. PubMed ID: 22746267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
